It’s been another busy year for Intouch. Over the course of 2019, we’ve celebrated our 20th anniversary, opened new offices, and kept tabs on a range of subjects relevant to the pharma marketing industry. If you, too, had a busy year and perhaps missed some of what we talked about, here’s a look back at our 10 most-read posts of 2019 — read on to get caught up and ready for 2020!

Complying With Colorado’s New Drug Price Transparency Law
Colorado House Bill 19-1131 went into effect on August 2, 2019. This POV describes the new law and how it could affect pharma marketers. The bill requires that any one-to-one communications between pharmaceutical representatives (or anyone communicating on their behalf) and prescribers must include written information about the wholesale cost of a drug, as well as the names of at least three generic equivalents.

The Health and Tech Trends That Will Shape Pharma Marketing in 2019
Everyone enjoys a trend forecast. We produced this POV with a focus on seven trends to keep an eye on in 2019 — how did our predictions play out? Read on to see how we did!

Pharma Patient Support Programs: What Does the Future Hold?
Patient-support services programs have become common in the pharmaceutical industry and are now considered table stakes for certain disease states. Yet government scrutiny has left some pharma companies wondering what to do with these programs in the future. This POV reviews the state of affairs and lays out recommendations from overall business, compliance, legal, and regulatory viewpoints.

California’s New Data Privacy Law: New Thinking on its Implications for Pharma
In June 2018, California took the privacy bull by the horns when it passed the California Consumer Privacy Act. Since then, we’ve been monitoring the legislative process and the discussions and reactions of opinion leaders. This POV provides the latest thinking on this law and its implications for pharma marketers. The law goes into effect on January 1, 2020 — is your brand ready?

What Matters Most: The Trends That Will Shape Pharma Marketing in 2020
Here, we give you a heads up about what’s most important for you to know, recommend ways that you can stay ahead of the curve, and provide links to additional reading. How will you work with these five trends in the years ahead?

FDA Finalizes Guidance on Mandatory Electronic Submission of Promotional Materials
On June 24, 2019, the Food and Drug Administration finalized its guidance on electronic submissions of promotional materials. Beginning on June 24, 2021, all 2253 filings of promotional materials, and all mandatory submissions of promotional materials for subpart H and E approvals must be submitted to the FDA via eCTD. This POV provides an overview of the most significant aspects of the guidance, including the most important changes from the 2015 draft version.

Facebook Private Messaging for Pages: What It Means for Pharma
An oldy but a goody. Facebook’s update around private messaging for Pages allows business Pages to communicate privately with visitors. Clients have asked how this feature works and whether it’s relevant for pharma; this post provides a brief overview.

Pharma Marketers: Have You Found Your Voice (Search)?
Voice search is more than just a passing fancy, and it’s changing the way people search for information, including info about their health. Here, we break down the voice search stats and opportunities for pharma marketers, and how to get up to speed if your brand isn’t there yet.

Mary Meeker’s 2019 Internet Trends Report — What Pharma Marketers Need to Know
Mary Meeker covered a lot of ground in her 2019 trends report. This year, her presentation covered a range of trends in sectors including e-commerce, advertising, data, education, employment, immigration, healthcare and more. While we won’t tackle every sector, we’ve identified three areas of interest for pharma marketers.

Six Ways Data Science Can Create More Efficient Marketing Experiences
Data science helps us find the hidden stories and patterns that can create efficient, valuable experiences. Maximizing the potential of the experience economy means combining business expertise, defining the core strategic problem(s), and using data scientists, technology, and machine-learning models to solve them. Check out this post for an in-depth look at creating meaningful experiences, plus six case studies that illustrate ways data science can help pharma marketers do more, faster and better, with less wasted time and money.